Clinical trials for Cancer in United States

Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers

Study ID: NCT05436327

Sponsor

M.D. Anderson Cancer Center

Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Study ID: NCT06608927

Sponsor

Arcus Biosciences, Inc.

Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases

Study ID: NCT03824327

Sponsor

Ohio State University Comprehensive Cancer Center

Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and Function

Study ID: NCT06081127

Sponsor

Northwestern University

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

Study ID: NCT06283927

Sponsor

Jasper Gerritsen

PRISAM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Melanoma

Study ID: NCT05546827

Sponsor

M.D. Anderson Cancer Center

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

Study ID: NCT06377527

Sponsor

M.D. Anderson Cancer Center

A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder

Study ID: NCT05137262

Sponsor

M.D. Anderson Cancer Center

Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma

Study ID: NCT06014827

Sponsor

City of Hope Medical Center

A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias

Study ID: NCT06397027

Sponsor

M.D. Anderson Cancer Center